IPP Bureau
India Pharmaceutical Market reports revenue decline in March 2022
By IPP Bureau - April 10, 2022
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
Masina hospital launches a tobacco cessation clinic
By IPP Bureau - April 10, 2022
The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention
Ministry of Ayush to organise two-day convention on World Homeopathy day
By IPP Bureau - April 09, 2022
World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary
Knowledge Centre for Pharmaceutical Continuous Manufacturing
By IPP Bureau - April 08, 2022
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
By IPP Bureau - April 08, 2022
Essent continues to broaden its highly characterized, low passage primary cell catalog
Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
By IPP Bureau - April 08, 2022
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
By IPP Bureau - April 08, 2022
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
IAVI and Moderna partner to tackle broad global health priorities
By IPP Bureau - April 08, 2022
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
By IPP Bureau - April 08, 2022
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Ineos to build acetonitrile plant in Germany
By IPP Bureau - April 08, 2022
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
By IPP Bureau - April 08, 2022
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Precaution dose for over 18 from April 10 at private vaccination centres
By IPP Bureau - April 08, 2022
About 96% of all 15+ population in the country have received at least one Covid-19 vaccine dose while about 83% of 15+ population has received both the doses
Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality
By IPP Bureau - April 08, 2022
The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
Sky announces the availability of its geko device on the Indian govt e-marketplace
By IPP Bureau - April 07, 2022
With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)
BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
By IPP Bureau - April 07, 2022
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
